Cómo citar
1.
Vindas Guerrero SE. Embolismo pulmonar. Rev.méd.sinerg. [Internet]. 5 de mayo de 2017 [citado 21 de diciembre de 2024];2(5):8-14. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/77
Resumen
El trombo generalmente se origina de los miembros inferiores en un 90-95% de los casos. Rara vez se origina en las venas de la pelvis, en las renales o extremidades superiores o en las cámaras del corazón derecho. Forma parte junto con la trombosis venosa profunda de la enfermedad tromboembólica venosa. El embolismo pulmonar (EP) es una condición que se asocia a una alta mortalidad y morbilidad. Se estima que más de 100.000 casos de EP ocurren anualmente.
Palabras clave
Embolismo. trombolisis. fibrinólisis. trombectomía quirúrgica. tromboembolismo venoso.
Citas
1. Törő et al. Evaluation of meteorological and epidemiological characteristics of fatal pulmonary embolism. Int J Biometeorol 2015; DOI 10.1007/s00484-015-1032-8.
2. C.Y. Wang et al. Risk factors and clinical features of acute pulmonary embolism in children from the community. Thrombosis Research 2016; 138: 86–90.
3. Ostovan MA, et al. Modification of Simplified Pulmonary Embolism Severity Index and its Prognostic Value in Patients with Acute Pulmonary Embolism. Heart, Lung and Circulation (2015), http://dx.doi.org/ 10.1016/j.hlc.2015.08.008.
4. Prandoni P et al. Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. N Engl J Med 2016; 375: 1524-31.
5. Marc A. Passman. Vena Cava Interruption and Pulmonary Embolism. In Cronenwett JL and Johnston WK. Rutherford’s Vascular Surgery. 8th ed. Editorial Elsevier; 2014: chap 153
6. Castuera AI, Fernández JH, Martínez EL, Muñoz IR. Tromboembolismo pulmonar. Medicine. 2015;11:5245-53.
7. Jaffer IH, Weitz JI. Antithrombotic Therapy. In Cronenwett JL and Johnston WK. Rutherford’s Vascular Surgery. 8th ed. Editorial Elsevier; 2014: chap 35.
8. Angriman et al. Wells Score and Poor Outcomes Among Adult Patients With Subsegmental Pulmonary Embolism: A Cohort Study. Clinical and Applied Thrombosis/Hemostasis 2014; 1-7; DOI: 10.1177/1076029614559772.
9. G. Gao, et al., Thrombolysis for acute intermediate-risk pulmonary embolism: A meta- analysis, Thromb Res (2015), http://dx.doi.org/10.1016/j.thromres.2015.09.012
10. Nasrin et al. Pulmonary embolism as a complication of an electrophysiological study: a case report. Journal of Medical Case Reports 2016; 10:89. DOI10.1186/s13256-016-0872-0
11. Menichetti et al. Use of rivaroxaban in an elderly patient with intermediate-low early mortality risk due to pulmonary embolism: a case report. Journal of Medical Case Reports (2015) 9:274 DOI 10.1186/s13256-015-0758-6.
12. Meinel FG, Nance JW Jr., Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, Goldhaber SZ, Bamberg F, Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-Analysis, The American Journal of Medicine (2015), doi: 10.1016/j.amjmed.2015.01.023.
13. Rucco et al. Neural hypernetwork approach for pulmonary embolism diagnosis. BMC Res Notes (2015) 8:617 DOI 10.1186/s13104-015-1554-5.
14. Ates et al. What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia?.Blood Coagulation and Fibrinolysis 2016, 27:252–258.
15. Li et al. Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb. Phlebology 2014; 29: 442-446.
2. C.Y. Wang et al. Risk factors and clinical features of acute pulmonary embolism in children from the community. Thrombosis Research 2016; 138: 86–90.
3. Ostovan MA, et al. Modification of Simplified Pulmonary Embolism Severity Index and its Prognostic Value in Patients with Acute Pulmonary Embolism. Heart, Lung and Circulation (2015), http://dx.doi.org/ 10.1016/j.hlc.2015.08.008.
4. Prandoni P et al. Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. N Engl J Med 2016; 375: 1524-31.
5. Marc A. Passman. Vena Cava Interruption and Pulmonary Embolism. In Cronenwett JL and Johnston WK. Rutherford’s Vascular Surgery. 8th ed. Editorial Elsevier; 2014: chap 153
6. Castuera AI, Fernández JH, Martínez EL, Muñoz IR. Tromboembolismo pulmonar. Medicine. 2015;11:5245-53.
7. Jaffer IH, Weitz JI. Antithrombotic Therapy. In Cronenwett JL and Johnston WK. Rutherford’s Vascular Surgery. 8th ed. Editorial Elsevier; 2014: chap 35.
8. Angriman et al. Wells Score and Poor Outcomes Among Adult Patients With Subsegmental Pulmonary Embolism: A Cohort Study. Clinical and Applied Thrombosis/Hemostasis 2014; 1-7; DOI: 10.1177/1076029614559772.
9. G. Gao, et al., Thrombolysis for acute intermediate-risk pulmonary embolism: A meta- analysis, Thromb Res (2015), http://dx.doi.org/10.1016/j.thromres.2015.09.012
10. Nasrin et al. Pulmonary embolism as a complication of an electrophysiological study: a case report. Journal of Medical Case Reports 2016; 10:89. DOI10.1186/s13256-016-0872-0
11. Menichetti et al. Use of rivaroxaban in an elderly patient with intermediate-low early mortality risk due to pulmonary embolism: a case report. Journal of Medical Case Reports (2015) 9:274 DOI 10.1186/s13256-015-0758-6.
12. Meinel FG, Nance JW Jr., Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, Goldhaber SZ, Bamberg F, Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-Analysis, The American Journal of Medicine (2015), doi: 10.1016/j.amjmed.2015.01.023.
13. Rucco et al. Neural hypernetwork approach for pulmonary embolism diagnosis. BMC Res Notes (2015) 8:617 DOI 10.1186/s13104-015-1554-5.
14. Ates et al. What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia?.Blood Coagulation and Fibrinolysis 2016, 27:252–258.
15. Li et al. Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb. Phlebology 2014; 29: 442-446.
Descargas
Los datos de descargas todavía no están disponibles.